Aspen review
Both molecules cost the same here, every dosage costs the same, and the vial carries an additive the trials never measured.
The verdict
Aspen publishes as low as $179 a month for a compounded GLP-1 with glycine or B12, read August 2026. The same figure covers both molecules. All dosages are stated at one price, across 51 jurisdictions.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 51
- From
- $179/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 51 jurisdictions
Aspen sells a compounded GLP-1 injection with an additive, describing a semaglutide path and a tirzepatide path but publishing one figure for both. Coverage runs to 51 jurisdictions.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. The pages describe the paths and the price rather than the clinician or the review schedule behind them.
Declining to charge more for the dual agonist is unusual and it removes a decision most sellers monetize. The cost of that simplicity is that the two paths are not priced separately, so a reader cannot see what either would cost alone.
What happens when the dose goes up?
All dosages are the same price, stated plainly. That answers the escalation question completely, and it is the strongest disclosure on the page.
What the price includes
Six months at $179 is $1,074, and the flat-dosage statement makes that a real total rather than an opening one. The figure is still qualified as low as, so something unpublished can lift it.
What it claims, and what it cites
The preparation is compounded with glycine or B12 rather than being the molecule alone. A pharmacy makes it to order and no agency reviews it before dispensing. The trials behind semaglutide and tirzepatide studied neither additive.
Where it holds up, and where it does not
- Strength: A single figure spans both molecules
- Strength: All dosages priced identically
- Strength: Coverage in 51 jurisdictions
- Strength: The additive is disclosed on the card
- Limitation: The two paths are not priced separately
- Limitation: The figure is still an as-low-as
- Limitation: No trial measured the additive
- Limitation: The pharmacy behind it is not identified
What the evidence says about this kind of treatment
The assessment above is about Aspen. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the escalation question closed and does not need the two molecules priced apart.
- Wrong for
- A reader who wants plain semaglutide without anything else in the vial.
How Aspen compares
| Seller | Who it suits | Go |
|---|---|---|
 Auren Rx | Readers who want tirzepatide without paying a premium for it | See Auren Rx → |
| Aspire Health | Readers who want the dose stated beside the vial and will do the arithmetic | See Aspire Health → |
| Balanced Hormone Health | Readers who would rather see a dose increase priced than hidden in a monthly figure | See Balanced Hormone Health → |
More GLP-1 telehealth sellers reviews: Fidelity Medical ClinicFORMFoundFridaysGalaGenesis Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is the dual agonist priced higher?
- No. Aspen publishes one figure and describes both paths under it.
- What happens when the dose goes up?
- Nothing, according to the seller: all dosages are stated at the same price.
- What is glycine or B12 doing in it?
- It is part of the compounded preparation Aspen sells. The trials behind either molecule tested the molecule alone.
- Is Aspen legit?
- Aspen is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Aspen expensive compared with other GLP-1 telehealth sellers?
- Aspen publishes a starting figure of $179/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Aspen right at the median. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.